Professor
Massachusetts Eye and Ear Infirmary Harvard
Boston, MA, United States
Gregory W. Randolph MD, FACS, FACE, FEBS (Endocrine), MAMSE Professor of Otolaryngology and the Claire and John Bertucci endowed Chair in Thyroid Surgical Oncology at Harvard Medical School and Surgeon at Massachusetts Eye & Ear Infirmary. Dr. Randolph has a thyroid and parathyroid surgical practice seeing patients and operating at both Mass Eye and Ear Infirmary and Mass General Hospital.
The bulk of his research on recurrent laryngeal nerve anatomy, preservation and monitoring during thyroid cancer surgery with focus on importance of laryngeal exam, recognition of lymph node metastasis, revision cancer surgery and neoadjuvant chemothereapy for advanced thyroid cancer and has over 300 peer reviewed publications. He has lead thyroid surgical missions to thyroid surgical units in St. Petersburg, Russia, Guangzhou, China, Kenya, rural India and in the Chernobyl region of the Ukraine. As a founding Steering Committee member of the World Congress on Thyroid Cancer (the largest thyroid cancer meeting in the world), he is currently codirecting the 2025 World Congress in Boston. He founded and directs the Harvard Thyroid and Parathyroid Surgery Course for surgeons and has directed international surgical courses in Italy, India, UK, Germany, Switzerland and Russia. He has received board certification from the European Union’s Board of Surgery in Neck Endocrine Surgery. He has published an endocrine surgical text: “Surgery of the Thyroid and Parathyroid Glands” published by Elsevier Saunders now in its third edition as well as a text centered on surgery of the recurrent laryngeal nerve “The Recurrent and Superior Laryngeal Nerves” published by Springer Publishers. He has served AAOHNS President in 2016-17. He is currently President of the Internantional Thyroid Oncology Group and Admnstrative Division Chair of the American Society of Head and Neck Surgery.
Disclosure information not submitted.
Advanced Thyroid Cancer: Updates on Therapeutic Options
Sunday, September 29, 2024
1:00 PM – 2:00 PM EDT
Update on the Focused Practice Designation (FPD) for Adult Complex Thyroid/Parathyroid Surgery
Sunday, September 29, 2024
3:00 PM – 3:45 PM EDT
Next Steps for Matching into Residency
Monday, September 30, 2024
8:00 AM – 9:00 AM EDT
Thyroid Radiofrequency Ablation: Why and How Should I Adopt This Into My Practice
Monday, September 30, 2024
1:00 PM – 2:00 PM EDT
AAO-HNS Thyroid Cancer Tumor Board
Monday, September 30, 2024
2:30 PM – 3:30 PM EDT
Parathyroid Gland Identification: More Than Meets the Eye
Monday, September 30, 2024
4:00 PM – 5:00 PM EDT